These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 24926093

  • 1. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study.
    Razmpoosh M, Sansregret A, Oligny LL, Patey N, Dormoy-Raclet V, Ducruet T, Bouron-Dal Soglio D.
    Am J Clin Pathol; 2014 Jul; 142(1):104-10. PubMed ID: 24926093
    [Abstract] [Full Text] [Related]

  • 2. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter J, Cheerala B.
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [Abstract] [Full Text] [Related]

  • 3. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD, Sellors JW, Sun HK, Zhang X, Bao YP, Jeronimo J, Chen W, Zhao FH, Song Y, Cao Z, Zhang SK, Xi MR, Qiao YL.
    Int J Cancer; 2014 Apr 01; 134(7):1715-24. PubMed ID: 24105727
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.
    Holladay EB, Logan S, Arnold J, Knesel B, Smith GD.
    Cancer; 2006 Dec 25; 108(6):451-61. PubMed ID: 17078096
    [Abstract] [Full Text] [Related]

  • 5. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
    Wang R, Li X, Qian M, Niu J, You Z.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar 25; 50(3):210-5. PubMed ID: 26268412
    [Abstract] [Full Text] [Related]

  • 6. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.
    Coll Antropol; 2010 Mar 25; 34(1):19-24. PubMed ID: 20432728
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: a follow-up study.
    Pacchiarotti A, Ferrari F, Bellardini P, Chini F, Collina G, Dalla Palma P, Ghiringhello B, Maccallini V, Musolino F, Negri G, Pisa R, Sabatucci I, Giorgi Rossi P.
    Int J Cancer; 2014 Feb 15; 134(4):897-904. PubMed ID: 23913416
    [Abstract] [Full Text] [Related]

  • 8. Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.
    Kanthiya K, Khunnarong J, Tangjitgamol S, Puripat N, Tanvanich S.
    Asian Pac J Cancer Prev; 2016 Feb 15; 17(7):3201-6. PubMed ID: 27509952
    [Abstract] [Full Text] [Related]

  • 9. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri.
    Negri G, Bellisano G, Zannoni GF, Rivasi F, Kasal A, Vittadello F, Antoniazzi S, Faa G, Ambu R, Egarter-Vigl E.
    Am J Surg Pathol; 2008 Nov 15; 32(11):1715-20. PubMed ID: 18769337
    [Abstract] [Full Text] [Related]

  • 10. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F.
    Acta Cytol; 2012 Nov 15; 56(5):506-14. PubMed ID: 23075891
    [Abstract] [Full Text] [Related]

  • 11. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, O'Leary JJ.
    J Clin Pathol; 2003 Jan 15; 56(1):56-63. PubMed ID: 12499437
    [Abstract] [Full Text] [Related]

  • 12. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].
    Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350
    [Abstract] [Full Text] [Related]

  • 13. Staining characteristics of p16INK4a: is there a correlation with lesion grade or high-risk human papilloma virus positivity?
    Ozgul N, Cil AP, Bozdayi G, Usubutun A, Bulbul D, Rota S, Kose MF, Biri A, Haberal A.
    J Obstet Gynaecol Res; 2008 Oct 25; 34(5):865-71. PubMed ID: 18958930
    [Abstract] [Full Text] [Related]

  • 14. Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women.
    Luo H, Lian Y, Tao H, Zhao Y, Wang Z, Zhou J, Zhang Z, Jiang S.
    BMC Cancer; 2024 Sep 20; 24(1):1171. PubMed ID: 39304838
    [Abstract] [Full Text] [Related]

  • 15. The triage of low-grade cytological abnormalities by the immunocytological expression of cyclin-dependent kinase inhibitor p16INK4a versus Human Papillomavirus test: a real possibility to predict cervical intraepithelial neoplasia CIN2 or CIN2+.
    Stănculescu R, Brătilă E, Bauşic V, Vlădescu T.
    Rom J Morphol Embryol; 2013 Sep 20; 54(4):1061-5. PubMed ID: 24399002
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
    Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, Zhang X, Chang BF, Zhang SK, Guo HQ, Qiao YL.
    Oncotarget; 2016 Apr 19; 7(16):21181-9. PubMed ID: 27029033
    [Abstract] [Full Text] [Related]

  • 17. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.
    Redman R, Rufforny I, Liu C, Wilkinson EJ, Massoll NA.
    Arch Pathol Lab Med; 2008 May 19; 132(5):795-9. PubMed ID: 18466028
    [Abstract] [Full Text] [Related]

  • 18. TOP2A/MCM2, p16INK4a, and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions.
    Del Moral-Hernández O, Hernández-Sotelo D, Alarcón-Romero LDC, Mendoza-Catalán MA, Flores-Alfaro E, Castro-Coronel Y, Ortiz-Ortiz J, Leyva-Vázquez MA, Ortuño-Pineda C, Castro-Mora W, Illades-Aguiar B.
    BMC Cancer; 2021 Jan 07; 21(1):39. PubMed ID: 33413211
    [Abstract] [Full Text] [Related]

  • 19. An evaluation of the diagnostic and prognostic significance of p16(INK4a) /p21(WAF1/Cip1) immunostaining in squamous intraepithelial lesions of the uterine cervix using liquid-based cytology specimens.
    Ishida K, Araki A, Kobayashi M, Taniyama K, Nabika T, Nagasaki M.
    Diagn Cytopathol; 2014 Feb 07; 42(2):125-33. PubMed ID: 23754829
    [Abstract] [Full Text] [Related]

  • 20. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents.
    Hu L, Guo M, He Z, Thornton J, McDaniel LS, Hughson MD.
    Mod Pathol; 2005 Feb 07; 18(2):267-73. PubMed ID: 15492761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.